300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Oman
Tajikistan
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Kenya
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Canada
United Kingdom
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in Middle East (August 2026)

The most active venture capital funds and angel investors investing in Middle East Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Middle East Life Science startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Israel Innovation Authority
VC Fund
6 Israel, United States, Mali Grant, Seed, Pre-Seed Health Care, Artificial Intelligence, Biotechnology $130k–$5M
TRANGELS
VC Fund
6 Turkey, United States, Estonia Seed, Pre-Seed, Angel Software, Information Technology, Artificial Intelligence $29k–$1.4M
Egypt Ventures
VC Fund
5 Egypt, United States, The Netherlands Seed, Venture - Series Unknown, Pre-Seed Software, Information Technology, FinTech $28k–$120M
Integra Holdings
VC Fund
4 Israel Seed, Series B, Series F Biotechnology, Pharmaceutical, Life Science
Sapir Venture Partners
VC Fund
4 Israel, United States, United Kingdom Seed, Pre-Seed, Series A Software, Biotechnology, Analytics $1.3M–$40M
aMoon Fund
VC Fund
4 United States, Israel, France Series B, Series A, Series C Health Care, Biotechnology, Medical $5.7M–$93M
FutuRx
VC Fund
3 Israel Seed Biotechnology, Life Science, Biopharma
Grove Ventures
VC Fund
3 Israel, United States Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $3.5M–$74M
Pitango VC
VC Fund
3 Israel, United States, China Series B, Series A, Series C Software, Health Care, Information Technology $4M–$100M
OrbiMed
VC Fund
3 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $10M–$183M
Neo Ventures
VC Fund
3 United States, United Kingdom, Israel Seed, Series A Software, Artificial Intelligence, SaaS $500k–$24M
Acasia Group
VC Fund
3 Egypt, United States, Nigeria Seed, Angel, Venture - Series Unknown E-Commerce, Financial Services, Mobile $50k–$2.6M
Alex Angels
VC Fund
2 Egypt, Denmark, The Netherlands Seed, Pre-Seed, Convertible Note E-Commerce, Logistics, Food and Beverage $28k–$1.6M
Ibtikar Fund
VC Fund
2 Palestinian Territory, United States, Jordan Seed, Pre-Seed, Series A Software, Artificial Intelligence, SaaS $60k–$2M
Minrav
VC Fund
2 Israel, Malaysia Series A Health Care, Hospital, Wellness $10M–$10M
Alexandria Fund
VC Fund
2 Egypt Seed, Debt Financing Biopharma, Life Science, Biotechnology
Hult Alumni Angels
VC Fund
2 Egypt Seed, Debt Financing Biopharma, Life Science, Biotechnology
Annex Investments
VC Fund
2 United Arab Emirates, Oman, Saudi Arabia Seed, Pre-Seed, Series A Information Technology, Software, Artificial Intelligence $100k–$6.5M
Jerusalem Venture Partners (JVP)
VC Fund
2 United States, Israel, United Kingdom Series A, Series B, Seed Software, Cyber Security, Enterprise Software $1.5M–$43M
Grok Ventures
VC Fund
2 Australia, United States, Singapore Series A, Seed, Series B Renewable Energy, Energy, Software $808k–$151M
RMGP Biopharma Investment Fund
VC Fund
2 Israel Seed, Series B Biotechnology, Biopharma, Life Science
Genesis Park
VC Fund
2 United States, Israel Private Equity, Debt Financing Health Care, Construction, Manufacturing $2.5M–$200M
SOSV
VC Fund
2 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Johnson & Johnson Robotics and Digital Solutions
VC Fund
2 United States, Israel, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $300k–$100M
Takeda Ventures
VC Fund
2 United States, United Kingdom, Israel Series A, Series B Biotechnology, Health Care, Therapeutics $10M–$130M
Arancia International
VC Fund
2 Israel, United States, Malaysia Series A, Series B Health Care, Biotechnology, Life Science $7.5M–$17M
fresh.fund
VC Fund
2 Israel, United States, Norway Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $300k–$21M
Cancer Focus Fund
VC Fund
2 Israel, United States, Germany Venture - Series Unknown, Series A, Seed Biotechnology, Medical, Health Care $4.5M–$47M
First Star Ventures
VC Fund
2 United States, Canada, Israel Seed, Pre-Seed, Series A Software, Artificial Intelligence, Biotechnology $575k–$15M
Oryx Fund
VC Fund
2 United Arab Emirates, Saudi Arabia, Oman Seed, Pre-Seed, Series A Software, SaaS, FinTech $1000k–$13M
Pontifax
VC Fund
2 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $6.3M–$130M
PeakBridge
VC Fund
2 Israel, United States, United Kingdom Series A, Seed, Series B Food and Beverage, Health Care, Food Processing $501k–$50M
LoftyInc Capital
VC Fund
2 United States, Nigeria, Egypt Seed, Pre-Seed, Venture - Series Unknown Financial Services, FinTech, Software $100k–$10M
Keiretsu Forum
VC Fund
1 United States, India, Turkey Seed, Series A Health Care, Software, Biotechnology $85k–$10M
Selcan Yilmaz
Angel
1 Turkey Series A Life Science, Biotechnology, Manufacturing
TÜBİTAK
VC Fund
1 Turkey, United States, United Kingdom Grant, Pre-Seed, Seed Software, Artificial Intelligence, Health Care $4k–$521k
Almoayed Ventures
VC Fund
1 United States, India, Bahrain Seed, Pre-Seed, Series A FinTech, Information Technology, Payments $1.2M–$15M
Rationalwave Capital Partners
VC Fund
1 United States, Israel, Trinidad and Tobago Seed, Pre-Seed Analytics, Machine Learning, Artificial Intelligence $1.3M–$8.8M
Trust Ventures
VC Fund
1 United States, Brazil, Israel Seed, Series A, Series B Health Care, Software, Information Technology $3.2M–$200M
Figen Korun
Angel
1 Turkey Seed, Pre-Seed, Series A E-Commerce, FinTech, Software $18k–$2M
Okan Erol
Angel
1 Turkey, United States Seed, Angel, Pre-Seed Biotechnology, AgTech, Software $52k–$350k
M Ventures
VC Fund
1 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Ozlem Tumer Eke
Angel
1 Turkey Grant AgTech, Life Science, Biotechnology
Yasemin Mistikoglu
Angel
1 Turkey Grant AgTech, Life Science, Biotechnology
Milk and Honey Investments
VC Fund
1 Israel Series A Life Science, Organic Food, Biotechnology
Ahmed Abdelhamid
Angel
1 Egypt, United States Seed, Convertible Note Big Data, Aerospace, Biopharma $1M–$3M
Averroes Ventures
VC Fund
1 Egypt, United Arab Emirates Seed, Convertible Note Logistics, Transportation, Delivery $500k–$2.5M
HBL Hadasit Bio Holdings
VC Fund
1 Israel Series A, Series B Biotechnology, Medical, Health Care
Office of the Chief Scientist
VC Fund
1 Israel Seed Health Care, Biotechnology, Hardware
Talisman Capital Partners
VC Fund
1 United States, Israel, Hong Kong Series A, Seed, Series B Information Services, Pet, News
Access all 50 investors in Middle East Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Israel Innovation Authority
VC Fund · Jerusalem, Yerushalayim, Israel · 6 investments in Middle East Life Science startups

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Biotechnology
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Israel, United States, Mali

Investor stats

  • Total investments: 200
  • Round size: Seed $500k–$5M; Grant $130k–$3.5M; Pre-Seed $150k–$2.1M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
  • NanoGhosts — NanoGhosts’ technology is based on its founder’s research, that the Technion's commercial unit has patented in the U.S. and Europe.
  • GeoRank Studio — Get your business ranked on Google, cited by ChatGPT & Perplexity, and protected from reputation damage. Specialist SEO and GEO agency. Free consultation.
Show all investments...

TRANGELS
VC Fund · Istanbul, Istanbul, Turkey · 6 investments in Middle East Life Science startups

Early Stage Investment Fund and Network

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Turkey, United States, Estonia

Investor stats

  • Total investments: 59
  • Round size: Seed $67k–$1.4M; Angel $100k–$500k; Pre-Seed $29k–$500k
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Zippsi — Zippsi connects individual and corporate clients with vehicle leasing companies in a quick, efficient and smart way.
  • Trawell Data — Trawell Data is a mobile data services company that provides travelers to use mobile data on their mobile phones without changing phones or sim cards. It enables the phone to digitally connect and use the local operator. Trawell Data was established in 2015 and is headquartered in Syosset, New York.
  • Visionteractive — Visionteractive develops social media based, fun and interactive physical and digital products, bridging the gap between online and actual world. The company aims to bring a brand together with the target audience by developing various creative products, while enhancing the memorability owing to the interactive experience with the users.Visionteractive was founded on 2013 and is based in Turkey.
Show all investments...

Egypt Ventures
VC Fund · El Cairo, Valle del Cauca, Colombia · 5 investments in Middle East Life Science startups

Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.

Show more...

Investment focus

  • Industry: Software, Information Technology, FinTech
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Egypt, United States, The Netherlands

Investor stats

  • Total investments: 38
  • Round size: Seed $100k–$3M; Pre-Seed $28k–$2M; Venture - Series Unknown $3.2M–$120M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Flend — Egypt’s first tech enabled, data driven financing solutions platform dedicated to small businesses.
  • D OCC Hub — Smart Incident Management Solutions
  • InfiniLink — Empowering Hyperscale Datacenters Building Energy-Efficient Ultra-High-Speed Connectivity Solutions
Show all investments...

Integra Holdings
VC Fund · Wallisellen, Zurich, Switzerland · 4 investments in Middle East Life Science startups

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Life Science
  • Stage:Seed, Series B, Series F
  • Geography: Israel

Investor stats

  • Total investments: 8
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
  • Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
  • Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Show all investments...

Sapir Venture Partners
VC Fund · 4 investments in Middle East Life Science startups

Early Stage VC

Show more...

Investment focus

  • Industry: Software, Biotechnology, Analytics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 21
  • Round size: Seed $1.3M–$10M; Series A $10M–$40M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
  • Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
  • DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
Show all investments...

aMoon Fund
VC Fund · Ra'anana, HaMerkaz, Israel · 4 investments in Middle East Life Science startups, 6 in the past 12 months

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 79
  • Round size: Series A $5.7M–$82M; Series B $22M–$93M; Series C $30M–$82M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
  • Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
  • Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
Show all investments...

FutuRx
VC Fund · Ness Ziona, HaMerkaz, Israel · 3 investments in Middle East Life Science startups

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Biopharma
  • Stage:Seed
  • Geography: Israel

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
  • Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
  • Bsense Bio Therapeutics — Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders. Bsense pioneers a novel approach targeting multiple hyperexcitability-related mechanisms using a single compound, to achieve greater efficacy and safety.
Show all investments...

Grove Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Middle East Life Science startups, 9 in the past 12 months

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners with seed and early-stage founders

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 73
  • Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $185M in 2022

Portfolio highlights

  • LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
  • Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
  • FormX — California's trusted sustainable builders. FormX delivers fully customized single-family homes, ADUs, and backyard offices built faster with component-based modular construction.
Show all investments...

Pitango VC
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in Middle East Life Science startups

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: Israel, United States, China

Investor stats

  • Total investments: 301
  • Round size: Series A $4M–$50M; Series B $8.1M–$55M; Series C $8.2M–$100M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $175M in 2023

Portfolio highlights

  • Convizit — Convizit's AI automatically captures user actions, adds properties, and delivers this behavioral data directly into your analytics and marketing platforms.
  • Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
  • QuantHealth — QuantHealth is an AI company that provides a platform to simulate clinical trials in order to accelerate and de-risk drug development.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 3 investments in Middle East Life Science startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 653
  • Round size: Series A $10M–$150M; Series B $24M–$150M; Series C $18M–$183M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • CardiAQ Valve Technologies — CardiAQ Valve Technologies (CVT), a privately held company, is developing innovative approaches to heart valve replacement and is initially focused on transcatheter mitral valve implantation (TMVI).
  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • Acceleron Pharma — At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Neo Ventures
VC Fund · Sofia, Grad Sofiya, Bulgaria · 3 investments in Middle East Life Science startups

Neo Ventures is a venture capital investment platform focused on deep tech, funds and high-growth startup portfolio.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 18
  • Round size: Seed $500k–$2.9M; Series A $2.3M–$24M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Bulbi — Bulbi is a child development platform designed to help parents discover online and face-to-face educational activities for their children.
  • Convex — All gas, no breakages. Convex is the reactive backend platform that keeps up with you and your agents.
  • Extend Robotics — Extend Human Capabilities Beyond Physical Presence
Show all investments...

Acasia Group
VC Fund · Cairo, Al Qahirah, Egypt · 3 investments in Middle East Life Science startups

Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Mobile
  • Stage:Seed, Angel, Venture - Series Unknown
  • Geography: Egypt, United States, Nigeria

Investor stats

  • Total investments: 39
  • Round size: Seed $50k–$2.6M; Angel $200k–$300k
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Bosta — Bosta provides an on-demand courier app with a B2C focus, allowing users to send parcels to their customers. The platform connects its users to couriers and allows them to monitor the status of the delivery of the package. Bosta was founded in 2017 and is headquartered in Cairo, Al Qahirah, Egypt.
  • EFG EV Fintech — EFG EV Fintech is investing in startups and bolstering the Fintech ecosystem in the process. EFG EV Fintech combines the financial know-how of EFG Hermes and entrepreneurial expertise of Egypt Ventures to launch the a Fintech-focused startup accelerator.They invest in rising Fintech startups with the potential to grow domestically and expandbeyond the Egyptian market. EFG EV Fintech also provides innovators with the fully integrated services they need to thrive – from funding to mentorship, to training, and office space.
  • Tagaddod — Tagaddod is a renewable Energy and Waste Management Egyptian company, started in February 2013 and operating in Cairo –Egypt. Currently focusing on clean fuels, Tagaddod is working on Biodiesel production from Vegetable Oils. Biodiesel is a fuel alternative that is produced from waste vegetable oils and used in conventional diesel engines, whichcan directly substitute for or extend supplies of traditional petroleum diesel.
Show all investments...

Alex Angels
VC Fund · Alexandria, Al Iskandariyah, Egypt · 2 investments in Middle East Life Science startups

Alexandria Business Angels Network

Show more...

Investment focus

  • Industry: E-Commerce, Logistics, Food and Beverage
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: Egypt, Denmark, The Netherlands

Investor stats

  • Total investments: 31
  • Round size: Seed $100k–$1.2M; Pre-Seed $28k–$1.6M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $1.9M in 2020

Portfolio highlights

  • Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.
  • AgriCash — AgriCash is 1st AgriFinTech app Provides PNPL service for the agricultural sector in Egypt
  • Poultry Sync — Take your poultry production operation to the next level and leverage artificial intelligence to boost performance, save cost, control fraud, and increase efficiency.
Show all investments...

Ibtikar Fund
VC Fund · Ramallah, West Bank, Palestinian Territory · 2 investments in Middle East Life Science startups

Ibtikar (Innovation, in Arabic) is a disruptive fund that will invest in innovative Palestinian companies. Ibtikar’s investments begin at the seed level through local accelerators, continue in post-acceleration phases and can also include series A investments in its portfolio companies. Through this investment strategy we aim to close a criticalfunding gap between acceleration and VC and other later-stage investors. Our goal is to maximize return for our investors by helping high-potential Palestinian companies answer regional and global needs. We will do this through direct support from our management team and select group of advisors, and will leverage the strong network of our investors and partners for the benefit of each of our portfolio companies.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Palestinian Territory, United States, Jordan

Investor stats

  • Total investments: 36
  • Round size: Seed $150k–$2M; Pre-Seed $60k–$750k
  • Lead/follow: 64% lead, 36% follow
  • Last fund: Likely still investing — raised $15M in 2022

Portfolio highlights

  • Nabeeh — Nabeeh is an online platform that allows users to book housekeeping, cleaning services, maintenance, repairs, and renovation services.
  • gamiphy — GAMIPHY is a user engagement and retention platform that equips brands in different industries with tools proven to increase customer reach and loyalty such as branded mini games, playable Ads and digital loyalty programs. The tools and techniques offered by GAMIPHY can be either integrated into existing websites and apps, or can be used to createplatform-independent solutions. The available solutions are diverse, fully customizable, DIY, and are guaranteed to improve each customer journey, thus shorten the path to earn the loyalty sought after.
  • DataQueue — Discover essential strategies for AI readiness with DataQueue. Learn how to prepare your business, choose the right AI tools, and develop a strategic AI plan for future success
Show all investments...

Minrav
VC Fund · Ashdod, HaDarom, Israel · 2 investments in Middle East Life Science startups

Minrav provides engineering and construction services.

Show more...

Investment focus

  • Industry: Health Care, Hospital, Wellness
  • Stage:Series A
  • Geography: Israel, Malaysia

Investor stats

  • Total investments: 4
  • Round size: Series A $10M–$10M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
  • Qualitas Health — Qualitas Health Group aims to serve patients through a network of 500 clinics by 2022 with quality healthcare services across the Asia Pacific.
Show all investments...

Alexandria Fund
VC Fund · 2 investments in Middle East Life Science startups

Alexandria Fund

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Seed, Debt Financing
  • Geography: Egypt

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing R&D services to the region's scientific sectors.
Show all investments...

Hult Alumni Angels
VC Fund · 2 investments in Middle East Life Science startups

Hult Alumni Angels

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Seed, Debt Financing
  • Geography: Egypt

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing R&D services to the region's scientific sectors.
Show all investments...

Annex Investments
VC Fund · Abu Dhabi, Abu Dhabi, United Arab Emirates · 2 investments in Middle East Life Science startups

Annex Investments is a Multifaceted Hybrid Venture Single-Family Office, (Located in Abu Dhabi, United Arab Emirates), strategically blending the patient capital and long-term vision of a traditional SFO with the dynamic, high-growth strategies of a venture firm. We actively build businesses, forge strategic partnerships, and shape the future ofthe MENA business landscape. Our integrated approach is built upon four core pillars: Venture Capital, Joint Ventures/Strategic Partnerships, a proprietary Venture Studio and comprehensive Market Entry & Advisory services

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Arab Emirates, Oman, Saudi Arabia

Investor stats

  • Total investments: 15
  • Round size: Seed $1M–$6.5M; Pre-Seed $100k–$2M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Ovasave — Understnd your fertility & hormonal health with Ovasave. Affordable & science-backed care to protect your future fertility. Egg freezing packages. Subscribe now!
  • eMushrif — You no longer have to compromise on your child's safety on school transportation.
  • Keyper — Keyper simplifies real estate management for property owners, tenants, and partners. Manage portfolios, get market insights, apply for rent with flexible payment options, and explore partnership opportunities to earn passive income. Join Keyper today!
Show all investments...

Jerusalem Venture Partners (JVP)
VC Fund · Jerusalem, Yerushalayim, Israel · 2 investments in Middle East Life Science startups

JVP is a top VC firm with $1.9B AUM and 165 companies built, leading in AI, Cyber Security, Fintech, Insurtech and Climatech.

Show more...

Investment focus

  • Industry: Software, Cyber Security, Enterprise Software
  • Stage:Series A, Series B, Seed
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 191
  • Round size: Seed $1.5M–$8M; Series A $4.3M–$24M; Series B $10M–$43M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Reduxio — Overcome data gravity with ionir, a Kubernetes Data Services platform built for enterprises and optimized to run in Kubernetes.
  • ThetaRay — ThetaRay's big data analytics solutions are based on AI & machine learning, empowering businesses to find opportunities and threats hidden in their big data
  • Altair Semiconductor — Altair is a fabless semiconductor company based in Israel that is developing state of the art, ultra low power mobile WiMAX silicon solutions optimized for handsets and handheld devices.Altair was founded in May 2005 by former Texas Instruments executives with extensive broadband and wireless silicon experience. Their products are thesmallest, lowest power solutions in the industry, offering superb mobility performance and enabling the migration of WiMAX from a fixed wireless PC technology to a true next generation mobile technology.Altair's management and technology executives were among the founding team of Libit Signal Processing, a fabless chip company acquired by Texas Instruments in 1999 for $365 million. The company's world class scientists, algorithm, VLSI and software engineers have in the past, jointly developed over twenty complex mixed-signal silicon products, spanning six different broadband wired and wireless technologies.Altair is a principal member of the WiMAX Forum and a member of the IEEE802.16e.
Show all investments...

Grok Ventures
VC Fund · Surry Hills, New South Wales, Australia · 2 investments in Middle East Life Science startups

Backing a better tomorrow

Show more...

Investment focus

  • Industry: Renewable Energy, Energy, Software
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, Singapore

Investor stats

  • Total investments: 69
  • Round size: Seed $808k–$10M; Series A $3.3M–$63M; Series B $26M–$151M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Endolith — Endolith is a biotech company transforming sustainable mining by leveraging microbes, synthetic biology, and cloud computing to extract more critical minerals like copper from low-grade ores. Working with the many of the leading mining companies, Endolith is advancing its innovative technology to commercial scale. Recognized as a finalist in theBHP Unearthed BioMetals cohort and a member of the Alaska Critical Minerals Collaborative, Endolith is driving the future of mining with sustainable, efficient, and responsible solutions for the clean energy transition.
  • MAKO — Solving human problems with nature’s surfaces.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
RMGP Biopharma Investment Fund
VC Fund · 2 investments in Middle East Life Science startups

RMGP Biopharma Investment Fund is an investment Fund

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Life Science
  • Stage:Seed, Series B
  • Geography: Israel

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
  • Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
  • Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Show all investments...

Genesis Park
VC Fund · Houston, Texas, United States · 2 investments in Middle East Life Science startups

Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.

Show more...

Investment focus

  • Industry: Health Care, Construction, Manufacturing
  • Stage:Private Equity, Debt Financing
  • Geography: United States, Israel

Investor stats

  • Total investments: 24
  • Round size: Debt Financing $5.5M–$65M; Private Equity $2.5M–$200M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $275M in 2021

Portfolio highlights

  • Procare Ambulance — Official Twitter account of Procare Ambulance of Maryland.
  • T&R Recovery Group — Founded in 2022 by Thomas Isbell and Roy M. Serpa, T&R Recovery Group is committed to revolutionizing the landscape of trauma, addiction, and mental
  • GLASS BOX TECHNOLOGY INC — Glass Box Technology Inc offers customizable network, storage, security, and server solutions designed to meet the needs of the industries.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 2 investments in Middle East Life Science startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Johnson & Johnson Robotics and Digital Solutions
VC Fund · New Brunswick, New Jersey, United States · 2 investments in Middle East Life Science startups

Healthcare innovation wherever it originates.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 77
  • Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
  • Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
  • Glyphic Biotechnologies — We sequence proteins. Glyphic Biotechnologies is decoding the human proteome through full coverage, de novo protein sequencing at single molecule resolution to enable the development of novel therapeutics and diagnostics and, ultimately, a deeper understanding of life itself.
Show all investments...

Takeda Ventures
VC Fund · San Diego, California, United States · 2 investments in Middle East Life Science startups

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 104
  • Round size: Series A $10M–$58M; Series B $20M–$130M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
  • Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
  • Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

Arancia International
VC Fund · Guadalajara, Jalisco, Mexico · 2 investments in Middle East Life Science startups

Arancia International Inc is a part of Arancia Group in Mexico. We are long term investors in food, nutrition and biotechnology companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Life Science
  • Stage:Series A, Series B
  • Geography: Israel, United States, Malaysia

Investor stats

  • Total investments: 9
  • Round size: Series A $10M–$17M; Series B $7.5M–$11M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • NextFerm — NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value.At Nextferm, they aim to use their capabilities to lead this new and exciting world of better nutrition.
  • iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
  • The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.
Show all investments...

fresh.fund
VC Fund · Jerusalem, Yerushalayim, Israel · 2 investments in Middle East Life Science startups, 7 in the past 12 months

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, Norway

Investor stats

  • Total investments: 44
  • Round size: Seed $1.6M–$10M; Pre-Seed $300k–$6M; Series A $11M–$21M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Kimba — Kimba is the first sleep system that reads your body and responds to it silently and automatically every night, using the only sensory pathway that can reach a sleeping brain. Reserve your Kimba today!
  • CopilotKit — The Enterprise-Ready Frontend Stack for Agents. CopilotKit lets you integrate LLMs or agents with real-time context, UI control, and full flexibility.
  • Shifters AI — Shifters builds autonomous robotic teams for dangerous ground missions.
Show all investments...

Cancer Focus Fund
VC Fund · Shreveport, Louisiana, United States · 2 investments in Middle East Life Science startups

Cancer Focus Fund is an oncology-focused investment firm advancing breakthrough cancer therapies by partnering with leading scientists, institutions and early-stage companies.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: Israel, United States, Germany

Investor stats

  • Total investments: 10
  • Round size: Series A $5.4M–$28M; Venture - Series Unknown $4.5M–$47M
  • Lead/follow: 60% lead, 40% follow
  • Last fund: May invest from a new fund soon — raised $50M in 2019

Portfolio highlights

  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • March Biosciences — Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of
  • Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
Show all investments...

First Star Ventures
VC Fund · Boston, Massachusetts, United States · 2 investments in Middle East Life Science startups

Investing with conviction in visionary, technical founders inventing the future.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 63
  • Round size: Seed $1M–$7M; Pre-Seed $575k–$1.8M; Series A $4.2M–$15M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • iOrganBio — The Right Cells. Consistently. At Scale.
  • Extellis — Reliable Satellite Imagery at an Industrial Scale
  • Bedrock Energy — Bedrock Energy is developing drilling technology and advanced subsurface simulation software to enable geothermal heating and cooling. The company develops autonomous drilling technology and advanced subsurface simulation software to make geothermal heating and cooling more widespread, affordable, and accessible.
Show all investments...

Oryx Fund
VC Fund · Abu Dhabi, Abu Dhabi, United Arab Emirates · 2 investments in Middle East Life Science startups

Oryx Fund is a MENA-focused Investment fund from Hambro Perks. Investing in game-changing early-stage technology companies at late Seed and Series A, led by outstanding entrepreneurs in sectors we have deep expertise such as Fintech, Healthtech, Enterprise tech, Logistics tech, and Edtech.

Show more...

Investment focus

  • Industry: Software, SaaS, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Arab Emirates, Saudi Arabia, Oman

Investor stats

  • Total investments: 31
  • Round size: Seed $1M–$6.5M; Pre-Seed $1000k–$2.2M; Series A $5M–$13M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Armoir — Armoir is a luxury luggage brand that designs quality suitcases inspired by travel trunks.
  • Coraly — Coraly helps real estate teams create listing-ready content, qualify leads, manage transactions, and share client-ready Packs from one AI-powered platform.
  • Qanooni — The legal AI operating system for law firms. Qanooni connects your matters, precedents and 5,000+ cited legal authorities, inside Word and Outlook.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Middle East Life Science startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 117
  • Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $12M–$101M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
  • Otic Pharma — Otic Pharma is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT). The company has two platform technologies, each of which has the potential to be developed for multiple ENT indications. The company is currently developing anasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), a condition that affects more than 700 million people around the world every year. Otitis media is one of the most common disease seen in pediatric practice and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing OP-01 as an improved treatment option for acute otitis externa (“swimmers ear”). For more information on the company, please visit www.oticpharma.com
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

PeakBridge
VC Fund · Valletta, NA - Malta, Malta · 2 investments in Middle East Life Science startups

PeakBridge is a highly networked, global impact VC that funds and connects the people, technology and processes that will shape the future of food. We invest in visionary pioneers, from early stage to Series A-B, with scalable, protectable climate and health-focused technologies. At their core: a deep commitment to disrupting our food system whiledriving positive impact. Our team is spread across seven countries and includes pioneers of FoodTech investment and decades of deep Agri-Food operational and financial experience. Together, we create exceptional value for bold FoodTech entrepreneurs and investors. A member of the Edmond de Rothschild Private Equity partnership, PeakBridge is also the only venture capital firm that is an official partner of the world’s largest Agri-Food innovation initiative, EIT Food.

Show more...

Investment focus

  • Industry: Food and Beverage, Health Care, Food Processing
  • Stage:Series A, Seed, Series B
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 56
  • Round size: Seed $501k–$11M; Series A $4.5M–$17M; Series B $11M–$50M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely still investing — raised $106M in 2022

Portfolio highlights

  • Myota — Precision prebiotic products developed by gut microbiome scientists. Clinically proven to improve your mental and physical health, and patented.
  • Ilant Health — We offer a comprehensive solution that take the stress and stigma out of obesity treatment. We increase access, improve quality, and drive reduction in total cost of care.
  • KÄÄPÄ Biotech — Medicinal mushrooms, biotechnology, mycology, forestry, agroforestry, and food production.
Show all investments...

LoftyInc Capital
VC Fund · Carmel, California, United States · 2 investments in Middle East Life Science startups

LoftyInc Capital Management empowers Afropreneurs to build a prosperous and equitable future in Africa. We deliver value to both founders and investors.........

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Software
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United States, Nigeria, Egypt

Investor stats

  • Total investments: 170
  • Round size: Seed $100k–$5M; Pre-Seed $100k–$2.4M; Venture - Series Unknown $200k–$10M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: Likely still investing — raised $14M in 2021

Portfolio highlights

  • Cauridor — Cauridor is a Financial Services company.
  • WafR — WafR is a reward-based loyalty startup that allows users to earn phone recharges while shopping at retail shops.
  • Nucleon Security — Zero-Trust and ML-based Endpoint Detection and Response Platform #EDR #FDR #EndpointSecurity
Show all investments...

Keiretsu Forum
VC Fund · San Francisco, California, United States · 1 investments in Middle East Life Science startups

Keiretsu Forum is a global angel investor network with more than 2,500 accredited investor members throughout 47 chapters on 3 continents.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Series A
  • Geography: United States, India, Turkey

Investor stats

  • Total investments: 241
  • Round size: Seed $85k–$3.3M; Series A $778k–$10M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2015

Portfolio highlights

  • Bliss — Skip long waitlists and expensive therapy. Book licensed online therapists in multiple languages with culturally informed care.
  • BatteryPool — BatteryPool offers battery charging solutions for EV fleets and commercial vehicles.
  • Apriority Financial — Apriority Financial is a debt optimization platform that manages and optimizes employee personal debt.
Show all investments...

Selcan Yilmaz
Angel · 1 investments in Middle East Life Science startups

Selcan yilmaz is an Independent Financial Services Professional.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Manufacturing
  • Stage:Series A
  • Geography: Turkey

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Biolive — BIOLIVE was founded as a start-up company in Incubation Centre at Istanbul Technical University in 2016. The company transitioned to becoming a corporation with an investment from Vestel Ventures, a subsidiary of Zorlu Holding in 2017. Currently, the company produces bioplastic raw materials such as Bio-PE, Bio-PP, and Bio-ABS in scale-up andnext-gen materials such as plant-based leather and also offers sustainable solutions.
Show all investments...

TÜBİTAK
VC Fund · Ankara, Ankara, Turkey · 1 investments in Middle East Life Science startups

The Scientific and Technological Research Council of Turkey (TÜBİTAK) is the leading agency for management, funding and conduct of research in Turkey. It was established in 1963 with a mission to advance science and technology, conduct research and support Turkish researchers. The Council is an autonomous institution and is governed by a ScientificBoard whose members are selected from prominent scholars from universities, industry and research institutions. TÜBİTAK is responsible for promoting, developing, organizing, conducting and coordinating research and development in line with national targets and priorities. TÜBİTAK acts as an advisory agency to the Turkish Government on science and research issues, and is the secretariat of the Supreme Council for Science and Technology (SCST), the highest S&T policy making body in Turkey.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Grant, Pre-Seed, Seed
  • Geography: Turkey, United States, United Kingdom

Investor stats

  • Total investments: 41
  • Round size: Seed $50k–$161k; Grant $4k–$230k; Pre-Seed $30k–$521k
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • Navirid — Navirid is a technology company specializing in IoT and embedded systems, dedicated to developing advanced radar technologies and safety solutions to connect motorcyclists to life and enhance their riding experience.The radar-based systems we develop provide riders with real-time environmental awareness, establishing a new safety standard inmotorcycle use with critical features like blind spot detection, collision warning, and multi-target tracking.Our vision is to make motorcycles an integral part of the intelligent transportation ecosystem; our mission is to connect riders more firmly to life on every journey.
  • VulnHero — AI-Driven Offensive Security | Attack Surface Management | Exploit Intelligence | Continuous Testing
  • Viseur AI — Viseur AI delivers a cutting-edge medical imaging solution powered by artificial intelligence. Our platform provides robust, scalable, cost-effective long-term radiology and digital pathology solutions through end-to-end automation.
Show all investments...

Almoayed Ventures
VC Fund · Manama, Al Manamah, Bahrain · 1 investments in Middle East Life Science startups

Almoayed Ventures is the venture arm of Almoayed General W.L.L. The company focuses on partnering with investment professionals with a track record of supporting and scaling innovative businesses. The company also makes direct investments in passionate entrepreneurs and supports them throughout their journey.

Show more...

Investment focus

  • Industry: FinTech, Information Technology, Payments
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Bahrain

Investor stats

  • Total investments: 26
  • Round size: Seed $1.2M–$13M; Series A $8M–$15M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • BARQ — BARQ enables bullet delivery for any business. From e-commerce to food, e-groceries and various sectors, BARQ utilizes its state-of-the-art delivery technologies to deliver orders as fast as 15 minutes up to same day delivery service.BARQ converts retail outlets to micro-fulfilment centers/dispatching hubs making delivery faster &easier. Once a customer places an order through the business platform, order gets fulfilled by the closest retail outlet and delivered to the customer once ready for pick up (bullet delivery).BARQ also serves warehouses and fulfillment centers with several delivery options, 4hrs up to same day or next day, depending on the business’ need. While restaurants and food aggregators enjoy 30-45 minute delivery service & paying a delivery fee ONLY.
  • Erad — erad provides growth capital to online businesses. Connect your analytics and receive funding offers, for non-dilutive capital within 48 hours
  • Unipal — Unipal provides university students access to tailored discounts and promotions through a digital identification.
Show all investments...

Rationalwave Capital Partners
VC Fund · Scarsdale, New York, United States · 1 investments in Middle East Life Science startups

Rationalwave Capital Partners is a venture capital firm investing in technology companies both public and private. The firm is located in New York and founded by Mark Rosenblatt in 2003.

Show more...

Investment focus

  • Industry: Analytics, Machine Learning, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: United States, Israel, Trinidad and Tobago

Investor stats

  • Total investments: 12
  • Round size: Seed $1.3M–$8.8M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Aromyx — Aromyx pioneers the creation of tastes and smells using a quantitative measurement system developed with biotechnology, data science, and AI.
  • Brij — With one-touch, BRIJ allows consumers to gain product info, care instructions and discounts while you gain a deeper understanding of your consumer. Apps, paper manuals and hassles not required.
  • BactoByte LTD — BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs.Based on a proprietary novel basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with80-90% improvement of standard turnaround time.Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient.BactoByte has technology validation and partnerships with leading medical centers.
Show all investments...

Trust Ventures
VC Fund · Austin, Texas, United States · 1 investments in Middle East Life Science startups, 10 in the past 12 months

Trust Ventures is a venture capital firm that focuses on startups and provides knowledge and expertise in incumbent-heavy industries. The firm was founded in 2018 and is based in Austin, Texas, United States.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Brazil, Israel

Investor stats

  • Total investments: 67
  • Round size: Seed $3.2M–$23M; Series A $10M–$68M; Series B $9M–$200M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Fluxco — Procurement, leasing, service and warranty for padmount, substation, and distribution transformers from 100+ global suppliers.
  • Base Power — Base provides a battery-powered home energy service so you can enjoy power without interruption and save money. Now available in select regions of Texas.
  • Antora Energy — Antora converts low-cost, intermittent renewable electricity into a reliable, on-demand source of zero-emissions industrial heat and power.
Show all investments...

Figen Korun
Angel · Istanbul, Istanbul, Turkey · 1 investments in Middle East Life Science startups

Figen Korun

Show more...

Investment focus

  • Industry: E-Commerce, FinTech, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Turkey

Investor stats

  • Total investments: 13
  • Round size: Seed $18k–$2M; Pre-Seed $125k–$178k
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Ni-CAT Battery Materials and AI Company — Ni-CAT is working on AI-assisted research and development of next-generation battery materials, which is the key to the transition to battery electric vehicles. Ni-CAT believes that the speed of EV transition is still not enough to prevent global warming and replace carbon-based fuels in near future, and it is not related to money or resources. Webelieve that speeding up EV transition is possible with our novel methodology, which combines three approximation to the solution: our unique AI-assisted materials research, digitalized reactor farm and our novel surfactant-assisted synthesis.As the electrification of the automotive industry expands, we deliver state-of-the-art technologies to meet the industry’s high-quality standards. To help our customers to step up the EV transition, we will be working on our research and development of lower-cost/higher performance, ultra-high energy density battery materials to serve innovative solutions for a brighter future. With our expertise in the application of machine learning in material science, we are developing low cobalt/high nickel lithium cathode materials. Cathode determines the type of a lithium battery and is the limiting factor for nickel-based batteries. Further improvement in battery performance is possible through AI-assisted custom high nickel cathode materials with increased charge rate, charge to discharge ratio, tap density, or any other specifications. By our unique computer-controlled digital reactor farm, we numerize synthesis parameters and output specifications for the machine learning algorithm we have been developing.
  • Riskoptima — 0-DTE SPX options
  • Hummingdrone — Hummingdrone provides cutting-edge autonomous drones and software solutions designed specifically for the solar energy industry.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Okan Erol
Angel · 1 investments in Middle East Life Science startups

Okan co-founded Wordego and as CEO leads the company’s strategic, executive and managerial efforts. His executive management experience includes working as a Business Development Manager for French Chamber of Commerce, CEO for Imerys Minerals, CEO for Esen Minerals, and CEO for Steno Energy. Okan holds a BS degree in Computer Engineering fromGalatasaray University, an MBA from Sorbonne University and a PhD degree in Finance & Banking from Kadir Has University.

Show more...

Investment focus

  • Industry: Biotechnology, AgTech, Software
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Turkey, United States

Investor stats

  • Total investments: 4
  • Round size: Seed $52k–$350k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • WORDEGO — Transform your ecommerce business with Wordego. Leverage unique AI technology to segment visitors by value in real-time, personalizing campaigns for maximum efficiency. Boost your revenue by over 25% and reduce advertising costs by up to 30% with Wordego's precision analytics.
  • Nanomik Biotechnology — Biochemistry leading change in life sciences. With our proprietary technologies, we develop solutions for Crop Health, Animal Health and Food preservation.
  • MD Research & Development — MD Research & Development are into research and development of innovative products and methods needed in the field of radiation oncology.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 1 investments in Middle East Life Science startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 174
  • Round size: Seed $2.4M–$24M; Series A $5.6M–$50M; Series B $15M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • ApoGen Biotechnologies — Explore fast payout casinos that deliver winnings instantly or under 24 hours. List of the best payout casinos to get same day winnings.
Show all investments...

Ozlem Tumer Eke
Angel · Istanbul, Istanbul, Turkey · 1 investments in Middle East Life Science startups

Ozlem Tumer Eke is an angel Investor.

Show more...

Investment focus

  • Industry: AgTech, Life Science, Biotechnology
  • Stage:Grant
  • Geography: Turkey

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Nanomik Biotechnology — Biochemistry leading change in life sciences. With our proprietary technologies, we develop solutions for Crop Health, Animal Health and Food preservation.
Show all investments...

Yasemin Mistikoglu
Angel · 1 investments in Middle East Life Science startups

Yasemin Mistikoglu

Show more...

Investment focus

  • Industry: AgTech, Life Science, Biotechnology
  • Stage:Grant
  • Geography: Turkey

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Nanomik Biotechnology — Biochemistry leading change in life sciences. With our proprietary technologies, we develop solutions for Crop Health, Animal Health and Food preservation.
Show all investments...

Milk and Honey Investments
VC Fund · 1 investments in Middle East Life Science startups

The Land of Milk and Honey is an abundant location where life is simple and devoid of need. Both in brand-new real estate development projects and while professionally restoring and renovating houses, Milk and Honey Investments LLC aims to create distinctive spaces of abundance and healthy living.

Show more...

Investment focus

  • Industry: Life Science, Organic Food, Biotechnology
  • Stage:Series A
  • Geography: Israel

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.
Show all investments...

Ahmed Abdelhamid
Angel · Kortenberg, Vlaams-Brabant, Belgium · 1 investments in Middle East Life Science startups

Ahmed Abdelhamid is based out of Kortenberg, Flemish Region and is the Founder and Group Chief Executive Officer of Keheilan Asset Management. Ahmed previously worked at USAID Business Egypt as a Senior Investment Policy Advisor. Ahmed Abdelhamid attended Vlerick Business School.

Show more...

Investment focus

  • Industry: Big Data, Aerospace, Biopharma
  • Stage:Seed, Convertible Note
  • Geography: Egypt, United States

Investor stats

  • Total investments: 4
  • Round size: Seed $1M–$3M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing R&D services to the region's scientific sectors.
  • WideBot AI — WideBot is the first bot builder platform in the MENA region. We allow anyone to build his own intelligent chatbot without any coding or technical experience in just 10 minutes.
  • Wright Electric — Wright Electric, Inc. is building technologies for large commercial airplanes. The company is currently developing their flagship Airplane, the Wright 1, which will be a 186-seat single aisle airliner with an 800 mile range. The company hopes to achieve entry to service for the Wright 1 by 2030 and is working with commercial airlines includingeasyJet and VivaAerobus. In addition to the newly announced U.S. DOE’s ARPA-E funding, the company is funded by Y Combinator, the Clean Energy Trust and venture funds.
Show all investments...

Averroes Ventures
VC Fund · Cairo, Al Qahirah, Egypt · 1 investments in Middle East Life Science startups

Averroes Ventures helps and invests in entrepreneurial teams seeking to transform big ideas into game-changing companies. Averroes Ventures' team possesses years of combined experience in global business operation and management across a multitude of sectors to help achieve visions.

Show more...

Investment focus

  • Industry: Logistics, Transportation, Delivery
  • Stage:Seed, Convertible Note
  • Geography: Egypt, United Arab Emirates

Investor stats

  • Total investments: 5
  • Round size: Seed $500k–$2.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ILLA — ILLA Trucking for Logistics Solutions & Distribution
  • Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing R&D services to the region's scientific sectors.
  • Khazenly — Khazenly is an on-demand digital warehousing and fulfillment management platform that provides an omnichannel solution to help merchants digitize their businesses.
Show all investments...

HBL Hadasit Bio Holdings
VC Fund · Jerusalem, Yerushalayim, Israel · 1 investments in Middle East Life Science startups

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B
  • Geography: Israel

Investor stats

  • Total investments: 9
  • Lead/follow: no public data

Portfolio highlights

  • ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Show all investments...

Office of the Chief Scientist
VC Fund · Tel Aviv, Tel Aviv, Israel · 1 investments in Middle East Life Science startups

The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Hardware
  • Stage:Seed
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
  • Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
  • Immunovative Therapies — Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstandingincubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.
Show all investments...

Talisman Capital Partners
VC Fund · Columbus, Ohio, United States · 1 investments in Middle East Life Science startups

Talisman Capital Partners operates as a private investment company.

Show more...

Investment focus

  • Industry: Information Services, Pet, News
  • Stage:Series A, Seed, Series B
  • Geography: United States, Israel, Hong Kong

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • Bond Vet — We offer compassionate, thorough, & friendly pet care in a warm, comfortable environment. Walk in or book online.
  • Prilenia — Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders. Its lead asset is Pridopidine, a n oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children.The company wasfounded in 2018 and is based in Israel, the Netherlands, and Boston.
  • qServe Communications — At qServe Communications, it is their unique vision to be a one-stop source for all your maintenance and development needs. They understand the difficulty of locating reliable companies to meet all of your infrastructure requirements. qServe has built an answer to this problem, a national service network of in-house employees to deliver qualitymanagement, installation, erection, inspection and maintenance services to the communications industry.With their full spectrum of project and program management services, they drive your project from start to finish, becoming an integral part of your development team. Many of qServe Communications crews and staff bring many years of valuable experience in the development of communications systems and infrastructures. From Program and Project Management to in-house installation and maintenance services, qServe will work diligently to ensure your project's success.qServe has performed thousands of projects for clients including: AT&T Wireless Services, Alltel Mobile, Nextel, Sprint, Omnipoint, Bell Atlantic Mobile, Teligent, Metricom, American Tower, Crown Castle and SBA Communications Corporation.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 investors investing in Middle East Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists